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The incidence of acute kidney injury (AKI) is rising in individuals of all ages; however, elderly patients
(older than 65 years) are particularly susceptible to the development of AKI due to the structural and
functional deterioration of the kidneys associated with the aging process, a decreased renal reserve, the
presence of comorbidities, and the reduced ability to recover. Older patients with AKI carry an elevated
risk of both short-term and long-term mortality, and survivors are often left with chronic kidney disease
(CKD) that eventually progresses to end-stage renal disease (ESRD). Additionally, older patients with AKI
suffer from an impaired quality of life and decreased functional status, both of which contribute to
adverse outcomes. Maintaining adequate hydration and avoiding nephrotoxic agents are helpful in
warding off AKI in elderly individuals. No proven treatment measures exist for AKI in elderly individuals
except supportive therapy. A thorough understanding of the pathogenesis, etiology, clinical courses,
complications, and prognosis of AKI in the elderly population is vital to preemptively reduce the inci-
dence of AKI and hopefully create a better outcome.
Copyright  2013, Asia Paciﬁc League of Clinical Gerontology & Geriatrics. Published by Elsevier Taiwan
LLC. Open access under CC BY-NC-ND license.1. Introduction
Acute kidney injury (AKI), previously termed acute renal failure
(ARF), has attracted increasing attention in recent years as a result
of its rising incidence and its devastating effect on patients.1,2
Annually, AKI occurs in approximately 0.3e0.5% of community-
dwelling adults, 5e10% of all hospitalized patients, and 25e70% of
critically ill patients.2e7 Patients in whom AKI is diagnosed during
hospital admission have a threefold to sixfold higher risk for hos-
pital death and a threefold higher risk for prolonged hospital
stay.2,8 Consequently, AKI constitutes a public health emergency
that must be addressed.
Aging is associated with a decline in organ function and the
emergence of chronic diseases as a result of the accumulated
damages to these vulnerable organ systems.9 An analysis of
Medicare beneﬁciaries in the United States showed that the rate of
AKI increases stepwise from 13.6 episodes (66e69 years) to 18.1
episodes (70e74 years) to 24.9 episodes (75e79 years) to 34.2
episodes (80e84 years) to 46.9 episodes (85 years and older) per
1000 patient-years, respectively.10,11 This trend holds true for both
dialysis-requiring and nondialysis-requiring AKI.12 However, fewgy, National Taiwan Univer-
g District, Taipei 100, Taiwan.
linical Gerontology & Geriatrics. Pstudies speciﬁcally address AKI in the elderly population, despite
the continuous growth of this population and their higher chances
of experiencing AKI.13,14 In this review, we provide a brief
description regarding the clinical features, classiﬁcation schemes,
disease courses, and outcomes of AKI in the elderly population,
with a special focus on the inherent differences between the elderly
and the general population.
2. Incidence of AKI in the elderly
The incidence of AKI in the elderly has been steadily growing
across racial and geographic areas, especially among men.14
Although this trend can be partially explained by the improved
sensitivity of diagnostic methods and newer biomarkers, it is more
likely that a true increase in the number of AKI patients exists, thus
creating a silent epidemic. Few studies exist regarding the inci-
dence of AKI among elderly patients in Taiwan. Our group esti-
mated the incidence of AKI [deﬁned as maximal serum creatinine
(sCr) during admission divided by baseline sCr level, ratio 1.5] at
52.8% of all the elderly patients receiving major surgery associated
with intensive care unit (ICU) admissions.15 In China, a single-
center study reported the incidence of AKI at 14.8% among pa-
tients >80 years admitted to the hospital; most of these cases were
caused by sepsis.16 The wide variation in the incidence of AKI stems
directly from the population being studied, the circumstances
leading to AKI, and the deﬁnition of AKI used during the studies.ublished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
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3.1. Normal aging kidney
Kidney function declines after the biologic ages of 30e40
years.17 The classic works of Davies and Shock18 in the 1950s
established the notion of functional renal aging, with 50% of renal
function still remaining at age 90 years. This decline in renal
functionwas considered purely physiologic and did not account for
any comorbid conditions.19,20 The origin of renal senescence has
been associated with the renal vascular response to various medi-
ators (e.g., acetylcholine and angiotensin), but efforts dedicated to
reverse such effects have been mostly futile.21,22
Anatomically, the aging kidney can be discussed in microscopic
and macroscopic terms. Microscopically, the functional unit (i.e.,
nephron) is often accompanied by glomerulosclerosis, with
vascular tuft collapse, thickening of the glomerular basement
membrane, and intracapsular ﬁbrosis.23e25 Tubular atrophy and
interstitial ﬁbrosis with collagen deposition also progress with
aging.25 Moreover, arteriosclerosis, medial hypertrophy, and arte-
riolar hyalinosis tend to accumulatewith age, leading to glomerular
ischemia and nephron degeneration.24,25 The combination of the
aforementioned histologic changes constitute the ﬁnding of
nephrosclerosis, which can be quantiﬁed under light microscopy.26
A cross-sectional study from theMayo Clinic demonstrated that the
percentage of nephrosclerosis increases in a stepwise fashion with
aging (2.7% at 18e29 years; 16% at 30e39 years, 28% at 40e49
years; 44% at 50e59 years; 58% at 60e69 years, and 73% at 70e77
years).25 However, anatomical changes do not necessarily correlate
with changes in renal function. Other less frequently found phe-
nomena include shrunken glomeruli, decreased glomerular den-
sity, and diverticuli.27,28 Although renal weight decreases beyond
40e50 years of age,29 kidney volume does not decrease in parallel
fashion largely as a result of compensatory glomerular hypertrophy
and/or an increase in sinus fat.28 Abnormalities seen on ultrasound
or computed tomography (such as distorted renal contours, surface
lobulation, and markedly decreased size) are generally related to
comorbidities and not the aging process.30 Gross changes of the
aging kidney mainly involve parenchymal calciﬁcations, simple
renal cysts, and focal narrowing of renal arteries31; however, none
of these morphologic phenotypes readily imply a decline of renal
function.
3.2. Effect of aging on the development of AKI
The kidney behaves differently as it ages. Experimental studies
showed that older rats experience more severe kidney damage
during ischemia and reperfusion maneuvers as a result of reduced
antioxidant levels and higher oxidative stresses than do the kidneys
of their younger counterparts.32 Age also predisposes animals to
other nephrotoxic injuries, such as from hemoglobin.33 This
exquisite susceptibility to exogenous and endogenous stimuli could
be the result of structural and functional alterations during extreme
aging.
4. Risk factors for AKI in the elderly
Multiple factors predispose the elderly to AKI. With advanced
age, comorbidities including hypertension, diabetes mellitus, and
heart failure can damage renal vasculature and compromise renal
perfusion.34 Comorbidities are often associated with the use of
medications (such as angiotensin-converting enzyme inhibitors or
angiotensin receptor blockers) that can potentially increase the risk
of AKI.35 Nephrotoxins (such as contrast agents with iodine and
nonsteroidal anti-inﬂammatory drugs) are also used with higherfrequency in the elderly and predispose these patients to AKI.36
Additionally, degeneration of other organs might necessitate
various interventions or procedures that create occult insults to the
already vulnerable kidneys.37 Furthermore, preexisting chronic
kidney disease [as deﬁned according to Kidney Disease: Improving
Global Outcomes (KDIGO) guidelines] in the elderly could precede
the development of AKI.38 The risk of sepsis is also higher in the
elderly as a result of the decreased effectiveness of the immune
system, which also predisposes the elderly to the development
of AKI.39
Anatomical changes in the elderly are also responsible for their
susceptibility to AKI. AKI arising from a postrenal origin (e.g.,
benign prostatic hyperplasia) occurs in 25% of elderly patients.40 An
increasing risk of pelvic cancer (e.g., bladder, colorectal, and pros-
tate) with aging also contributes to a higher incidence of obstruc-
tive uropathy and subsequent AKI.41 Glomerular changes, such as
membranous glomerulopathy and amyloid depositions, are more
common in the elderly.42 These pathologic changes, along with
proteinuria, also predispose the elderly to the development of
subsequent renal injury.
5. Clinical features of AKI in the elderly
5.1. Etiology of AKI
Because the incidence of renal biopsy in the elderly is low, most
of the etiologies for AKI in the elderly are based on clinical judg-
ment, and the data are limited.43 According to one report, ischemia
(hypovolemia/hypotension) is responsible for half of the AKI cases,
followed by surgery (33.3%), sepsis (10%), and nephrotoxins (3%).44
Other larger studies suggested acute tubular necrosis as the most
common cause of AKI in the elderly (39%), and prerenal conditions
accounted for 30% of AKI.41,45 Nonetheless, all reports identiﬁed
prerenal or ischemic causes for the greatest proportion of AKI in the
elderly.
5.2. Clinical features
No study currently addresses the key clinical differences be-
tween the elderly and younger patients with respect to the onset of
AKI. Gong et al,44 in a small-scale study, found no signiﬁcant dif-
ferences between the age groups with respect to sex, laboratory
test results, proteinuria/hematuria, or disease severity scores
[Acute Physiology and Chronic Health Evaluation (APACHE)], except
for a longer hospital stay in the elderly group (p ¼ 0.038). Several
studies reported that aging diminishes the ability of the kidneys to
recover after AKI occurs.46,47 The putative mechanism might
involve the age-dependent decline in speciﬁc tubular cells with
regenerative potentials.48 Elderly patients with AKI fare worse than
their non-AKI counterparts during admission and carry a worse
prognosis, with higher short-term and long-term mortality even
after discharge from the index admissions.49
6. Diagnosis and classiﬁcation of AKI in the elderly
Historically, the diagnosis of AKI (or ARF) was based on different
criteria, depending on the percentage and the magnitude of the
serum creatinine or changes in the urine volume over different
intervals.50 For clariﬁcation, we will summarize the information in
the following paragraphs. The risk injury failure loss end-stage
(RIFLE) classiﬁcation system was established in 2004 by the Acute
Dialysis Quality Initiatives (ADQI) consensus as a practical classiﬁ-
cation scheme for AKI1 (Table 1). This classiﬁcation uniﬁes the
threshold of changes in the biologic parameters (i.e., sCr and urine
output) and limits the diagnostic window to 1 week. ADQI
Table 1
Risk injury failure loss end-stage (RIFLE) classiﬁcation of acute kidney injury.
sCr criteria GFR criteria Urine output criteria
Risk sCr increase 1.5-fold GFR decrease >25% Urine < 0.5 mL/kg/h for 6 h
Injury sCr increase 2-fold GFR decrease >50% Urine < 0.5 ml/kg/h for 12 h
Failure (1) sCr increase 3-fold
(2) sCr acute rise 0.5 mg/dL
if baseline sCr 4 mg/dL
GFR decrease >75% (1) Urine < 0.3 ml/kg/h for 24 h
(2) Anuria for 12 h
Loss Complete renal function loss
for >4 wk
End-stage End-stage renal disease,
deﬁned as renal functional
loss for >3 mo
GFR ¼ glomerular ﬁltration rate (ml/min/1.73 m2); sCr ¼ serum creatinine (mg/dL).
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network (AKIN). The diagnostic window was increased to 48 hours
in order to enhance sensitivity51 (Table 2). Both classiﬁcation sys-
tems are useful in predicting the outcomes of critically ill patients,
those with a wide spectrum of diseases, and those undergoing
various surgeries/procedures.52e57 Compared with non-AKI pa-
tients, RIFLE risk, injury, and failure classes of AKI are associated
with a 2.4-, 4.1-, and 6.4-fold higher risk of adverse outcomes,
respectively, in patients with AKI.58
Several biologic phenomena recognized in the elderly could
contribute to the failure of the outcome-prediction model whenwe
utilize these classiﬁcation systems.15 First, creatinine alone is never
a good marker for estimating renal function.59 Serum creatinine is
frequently affected by the rate of creatinine production and many
nonrenal issues, such as the overall nutrition status and the per-
centage of muscle mass (both of which are generally lower in the
elderly).60 Fluid overload or sepsis tend to develop more easily in
older patients, which causes a disproportionately lower rise in
sCr.61,62 In addition to the falsely low sCr levels, the rate of sCr
elevation in the elderly is also much slower than that of the general
population, leading to an artiﬁcially late diagnosis of AKI.63 Pre-
dictably, the use of sCr-based diagnosis and stratiﬁcation methods,
such as the RIFLE and AKIN schemes, will encounter limitations
when applied to a geriatric population. We recently identiﬁed that
age older than 76 years was associated with the failure of RIFLE to
accurately predict the outcomes of geriatric AKI patients.15
Many researchers are now looking to other promising bio-
markers for the diagnosis of AKI, with the hope of earlier detection
and the institution of preemptive measures59 (Table 3). Among
these biomarkers, neutrophil gelatinase-associated lipocalin
(NGAL) is the most well known. Plasma NGAL starts to elevate
within 48e72 hours of cardiopulmonary bypass and other cardiac
surgery-related AKI. Urinary NGAL elevation signiﬁcantly predicts
adverse outcomes in patients with AKI and sepsis, as well as in
patients seen in the emergency department and in the ICU.64,65
Levels of urinary liver-type fatty acid binding protein are also
predictive for postoperative AKI in cardiac surgery patients.66,67
Serum and urine interleukin-18 levels correlate fairly well with
the development of postcardiopulmonary bypass AKI but areTable 2
Acute Kidney Injury Network classiﬁcation of acute kidney injury.
sCr (48 h)
AKIN class I (a) sCr increase 1.5-fold
(b) sCr increase 0.3 mg/dL
AKIN class II sCr increase 2-fold
AKIN class III (a) sCr increase 3-fold
(b) sCr acute rise 0.5 mg/dL
if baseline sCr 4 mg/dL
AKIN ¼ Acute Kidney Injury Network; sCr ¼ serum creatinine (mg/dL).unreliable in the ICU or posttrauma settings.68 Serum and urine
cystatin C can be used to predict the development of AKI in post-
cardiac surgery patients and those who have undergone contrast-
induced nephropathy. Urine kidney injury molecule-1 is utilized
in postcardiac surgery cases.69 Due to the wide variation in the
deﬁnitions for AKI, clinical settings, study designs, and timing of the
biomarkers, there is no current consensus about which biomarker
should be used in which clinical scenarios. Furthermore, there are
no current studies addressing the application of these novel bio-
markers as risk predictors of AKI speciﬁcally in the elderly.
Diagnosis of AKI based on the International Classiﬁcation of
Disease (ICD) codes is controversial, as this method often un-
derestimates the true incidence of AKI.70,71 A recent study revealed
that utilizing ICD-10 coding for capturing the diagnosis of AKI in the
elderly could be highly speciﬁc (>95%) but not sensitive enough
(37e62%).72 This low sensitivity underscores the limitations of
administrative databases in the studies of AKI, especially in geri-
atric cases.
7. Treatment strategies
The general principles of treating AKI in the elderly are similar to
those of the other populations and involve treatment of life-
threatening complications such as dyselectrolytemia, refractory
metabolic acidosis, ﬂuid overload (pulmonary edema), uremic
bleeding, and uremic encephalopathy.73 The elderly are more sus-
ceptible to ﬂuid overload, and earlier interventions should be
instituted to prevent complications.61 The therapies delivered to
these fragile elderly patients can potentially do more harm than
good.74 Judicious use of medication including dose adjustments for
renal and liver dysfunction is vital for proper management of
complications in elderly patients with AKI. Nutritional support in
patients with AKI, particularly the elderly, is another underexplored
area.
The initiation of renal replacement therapy (RRT) in AKI is a
controversial issue, including early versus late initiation of RRT,
high versus low RRT dosages, and methods for administration of
RRT.75 However, when it comes to the elderly, shared decision-
making regarding life expectancy should be integrated into theUrinary output Miscellaneous criteria
Urine < 0.5 mL/kg/h for 6 h
Urine < 0.5 mL/kg/h for 12 h
(a) Urine < 0.3 mL/kg/h for 24 h
(b) Anuria for 12 h
Patients who receive renal
replacement therapy
Table 3
Available biomarkers in acute kidney injury.
Serum Urine
Cystatin C (þ) (þ)
Neutrophil gelatinase-associated lipocalin (NGAL) (þ) (þ)
L-type fatty acid binding protein (L-FABP) (þ) (þ)
Interleukin-18 (IL-18) (þ) (þ)
Kidney injury molecule-1 (KIM-1) () (þ)
Netrin-1 () (þ)
N-acetyl-b-D-glucosaminidase (NAG) () (þ)
a1-macroglobulin (a1-MG) () (þ)
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tient preferences.77 A time-limited trial of dialysis might be another
choice.78 Prognostic models for elderly patients with AKI are not yet
available, so decisions onwhether to initiate or discontinue RRT are
still made on an individual basis.
8. Courses and outcomes of AKI in the elderly
8.1. Mortality after AKI in the elderly
Elderly patients suffering from AKI have a high short-term
mortality (20e45%)11,41,45 that varies based on whether the AKI is
hospital acquired (higher mortality) or community acquired (lower
mortality).79 An intrinsic origin of AKI also carries a worse prog-
nosis than prerenal or postrenal origins for AKI.79 The overall out-
comes have improved in recent years despite an increase in
concomitant comorbidities.80 The short-term mortality associated
with AKI in the elderly has continued to decline along with the
mortality for the entire AKI population.45
Long-termmortality rates are also elevated in patients with AKI,
and patient age plays a signiﬁcant role.57 Patients with AKI have 90-
day, 6-month, 1-year, and 5-year survival rates ranging 46e74%,
55e73%, 57e65%, and 65e70%, respectively.81 Elderly patients with
AKI have even higher long-term mortality rates than their younger
counterparts, but the degrees of elevated risk vary.49,82 One report
found no signiﬁcant differences in the risk of death between
dialysis-requiring patients with AKI after cardiac surgery whowere
70 years of age, or <70 years.83 The effect of AKI on long-term
survival might be mitigated by the emergence of other comorbid-
ities, therefore deviating the results.13 The synergistic effects of
disease combinations represent a signiﬁcant confounder of study
interpretations.79
8.2. CKD and end-stage renal disease after AKI in the elderly
AKI is no longer considered a completely reversible condition,
and development of CKD and end-stage renal disease are often
reported. Diagnosis of AKI during admission is associated with 3e
20-fold higher risk of subsequent CKD in the ensuing months to
years.84e86 Furthermore, AKI after renal transplantation can exac-
erbate the risk of graft failure.56 A recent meta-analysis also high-
lighted the fact that patients >65 years in whom AKI has been
diagnosed have a signiﬁcantly higher chance of nonrecovery of
renal function than younger patients (relative risk 1.28; p < 0.01).46
However, interpretation of these studies should be conducted with
the understanding that mortality from AKI is an important
competing risk during the analyses. Results are also often
confounded by deﬁnitions of CKD.13,84 Mechanisms explaining
higher risks for CKD after AKI can be deducted from experimental
models and include diminished tubular epithelial cell proliferative
potentials, lower rates of cellular turnover, reduced growth factor
expression, and less capability to recruit progenitor cells to injury
sites for repair.48,878.3. Functional outcomes after AKI in the elderly
The quality of life (QoL) after AKI is rarely investigated in the
literature, and none of the available studies discuss the elderly. One
small-scale study suggested that AKI survivors have lower physical
health summary scores but similar mental health scores compared
with the general population [based on the 36-Item Short Form
Health Survey (SF-36)].88 Another small study suggested no sig-
niﬁcant decrease in QoL after 3 years of follow-up in dialysis-
requiring AKI survivors [based on the Medical Outcomes Study
(MOS-SF20) questionnaires].89 Ahlström et al90 identiﬁed lower
overall health-related QoL in dialysis-requiring AKI survivors at 2.4
years of follow-up. Another Finnish nationwide survey also reached
similar results (based on the EuroQoL instruments).91 However, it is
interesting to observe that these survivors perceived their health to
be as good as that of patients not requiring dialysis post-AKI.
In conclusion, the percentage of elderly individuals continues to
increase and this population consumes increasingly more health-
care resources, often with less favorable outcomes. The elderly are
more susceptible to the development of AKI due to their comor-
bidities, polypharmacy, and various interventions that introduce
injury to their kidneys. AKI in the elderly is often detected more
slowly or even masked, which increases the risk for complications
and poor outcomes. The development of AKI is associated with a
higher risk for mortality as well as long-term detrimental effects
such as CKD or end-stage renal disease in the elderly patient.
Healthcare providers must be more aware of AKI and its devas-
tating effects on the elderly and devote more resources to reducing
the incidence of AKI in this population.Conﬂicts of interest
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